This inventor holds 4 USPTO granted patents. Top assignees: University of Arkansas, Other. Active years: 2001-2006.
Company Filing History:
3 out of 849 
1 out of 834,350 Years Active: 2001-2006
Title: Richard Drake: Innovator in Viral Therapeutics
Introduction
Richard Drake is a notable inventor based in Little Rock, AR (US). He has made significant contributions to the field of viral therapeutics, particularly through his innovative work on herpes simplex virus type 1 thymidine kinases. With a total of 4 patents to his name, Drake's inventions have the potential to impact medical treatments significantly.
Latest Patents
One of Richard Drake's latest patents focuses on mutated herpes simplex virus type 1 thymidine kinases and their uses. This invention provides new site-specific HSV-thymidine kinase mutants that exhibit improved nucleoside analog metabolizing activity due to low or no thymidine phosphorylation ability. Additionally, the patent outlines a method for killing target cells using these mutants in combination with a prodrug. This innovative approach could lead to more effective treatments for viral infections.
Career Highlights
Throughout his career, Richard Drake has worked at the University of Arkansas, where he has contributed to various research initiatives. His work has been instrumental in advancing the understanding of viral mechanisms and therapeutic applications.
Collaborations
Richard has collaborated with notable colleagues, including Trenton Hinds and Cesar M Compadre. These partnerships have fostered a collaborative environment that enhances research and innovation in the field.
Conclusion
Richard Drake's contributions to viral therapeutics through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments for viral infections.